Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$6.69 - $14.54 $200,967 - $436,781
-30,040 Reduced 98.48%
465 $5,000
Q1 2024

Apr 25, 2024

SELL
$7.8 - $11.02 $29,546 - $41,743
-3,788 Reduced 11.05%
30,505 $265,000
Q4 2023

Feb 02, 2024

BUY
$3.85 - $12.84 $132,028 - $440,322
34,293 New
34,293 $419,000
Q2 2023

Aug 04, 2023

BUY
$3.67 - $8.64 $20,243 - $47,658
5,516 New
5,516 $39,000
Q4 2022

Feb 02, 2023

BUY
$1.73 - $2.89 $15,919 - $26,593
9,202 New
9,202 $25,000
Q2 2022

Aug 03, 2022

BUY
$1.48 - $4.28 $1,434 - $4,147
969 Added 191.88%
1,474 $2,000
Q3 2021

Oct 28, 2021

BUY
$17.25 - $26.63 $5,054 - $7,802
293 Added 138.21%
505 $10,000
Q2 2021

Aug 12, 2021

SELL
$16.31 - $23.64 $78,222 - $113,377
-4,796 Reduced 95.77%
212 $3,000
Q1 2021

Apr 26, 2021

BUY
$22.43 - $44.27 $99,589 - $196,558
4,440 Added 781.69%
5,008 $118,000
Q4 2020

Feb 02, 2021

SELL
$11.66 - $24.5 $3,556 - $7,472
-305 Reduced 34.94%
568 $13,000
Q3 2020

Oct 14, 2020

SELL
$9.27 - $13.14 $3,142 - $4,454
-339 Reduced 27.97%
873 $10,000
Q2 2020

Jul 13, 2020

BUY
$6.23 - $13.09 $7,550 - $15,865
1,212 New
1,212 $12,000
Q1 2020

Apr 29, 2020

SELL
$5.23 - $15.2 $7,050 - $20,489
-1,348 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$12.58 - $15.97 $2,276 - $2,890
-181 Reduced 11.84%
1,348 $18,000
Q3 2019

Oct 15, 2019

BUY
$10.73 - $17.33 $12,425 - $20,068
1,158 Added 312.13%
1,529 $23,000
Q2 2019

Jul 26, 2019

BUY
$11.11 - $17.34 $4,121 - $6,433
371 New
371 $4,000
Q4 2018

Jan 16, 2019

SELL
$9.08 - $14.34 $1,362 - $2,151
-150 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$12.83 - $16.45 $1,924 - $2,467
150 New
150 $2,000
Q1 2018

Apr 26, 2018

SELL
$12.67 - $24.69 $6,309 - $12,295
-498 Closed
0 $0
Q4 2017

Jan 10, 2018

BUY
$18.81 - $30.33 $3,724 - $6,005
198 Added 66.0%
498 $11,000
Q3 2017

Oct 25, 2017

BUY
$10.26 - $24.97 $3,078 - $7,491
300
300 $5,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $672M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.